BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July

Day

• 2
• 3
• 4
• 5
• 6
• 7
• 9
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 25
• 26
• 27
• 28

• Press Releases

  FDA Grants Priority Review to Merck’s Application for KEYTRUDA® (pembrolizumab) Plus Standard of Care as Perioperative Treatment for Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma

  February 25, 2025

   · 

  19 min read
• Press Releases

  U.S. Cell And Gene Therapy CDMO Market Size to Hit USD 33.24 Bn by 2034

  February 25, 2025

   · 

  1 min read
• Press Releases

  Bright Minds Biosciences to Participate at Three Healthcare Conferences in March 2025

  February 25, 2025

   · 

  1 min read
• Press Releases

  FDA Declined Invivyd’s Request to Expand Existing Emergency Use Authorization of PEMGARDA™ (pemivibart) to Include Treatment of Mild-to-Moderate COVID-19 For Immunocompromised Persons Who Have No Alternative Therapeutic Options; No Change to the Existing PEMGARDA EUA for Pre-Exposure Prophylaxis of COVID-19 in Certain Immunocompromised Patients

  February 25, 2025

   · 

  12 min read
• Press Releases

  BioCryst Reports Fourth Quarter and Full Year 2024 Financial Results and Upcoming Key Milestones

  February 25, 2025

   · 

  20 min read
• Press Releases

  BioStem Receives Institutional Review Board (IRB) Approval to Advance Clinical Trial Demonstrating the Therapeutic Benefits of BioREtain® Technology in Treating Venous Leg Ulcers

  February 25, 2025

   · 

  7 min read
• Press Releases

  Gylden’s 2025 Strategic Priorities for Advancing Innovative and Transformative Solutions for Infectious Diseases

  February 25, 2025

   · 

  7 min read
• Press Releases

  Cullinan Therapeutics to Participate in Upcoming March 2025 Investor Conferences

  February 25, 2025

   · 

  1 min read
• Press Releases

  BioCryst Announces Positive Results from APeX-P Trial for ORLADEYO® (berotralstat) in Pediatric Patients with Hereditary Angioedema Aged 2 to <12 Years

  February 25, 2025

   · 

  12 min read
• Press Releases

  BioNTech to Report Fourth Quarter and Full Year 2024 Financial Results and Corporate Update on March 10, 2025

  February 25, 2025

   · 

  2 min read